Feed/Investors/Gates Foundation

Gates Foundation

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Corporationgatesfoundation.orgSince 2025-10-08

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$101M

across 1 round

LATEST ROUND

Series A · $101M · 2025-10-08

CO-INVESTORS

named beside it

Rounds

The rounds this investor is named on, who it invests beside, and where it shows up.

Nilo[ PART ]

Nilo Therapeutics develops medicines that target neural circuits to restore immune balance in autoimmune and inflammatory disease.

Series A$101M2025-10-084 [ REPORTED LATER ]

Company	Round	Amount	Announced	Role
Nilo Nilo Therapeutics develops medicines that target neural circuits to restore immune balance in autoimmune and inflammatory disease.	Series A Verified against 1 of 4 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts.	$101M	2025-10-08	[ PART ]